Pre-exposure to ethanol, but not to caffeine and nicotine, induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®-Reference-Cited by-同舟云学术

Pre-exposure to ethanol, but not to caffeine and nicotine, induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®

Published:2013-09 Issue: Volume:110 Page:231-237
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

de la Peña June Bryan I.,dela Peña Irene Joy I.,Lee Hye Lim,dela Peña Ike,Shin Chan Young,Sohn Aee Ree,Cheong Jae Hoon

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference67 articles.

1. Neural basis of inhalant abuse;Balster;Drug Alcohol Depend,1998

2. Lict and illicit drugs: the Consumers Union report on narcotics, stimulants, depressants, inhalants, hallucinogens, and marijuana—including caffeine, nicotine and alcohol;Becker;West J Med,1974

3. Nicotine addiction;Benowitz;N Eng J Med,2010

4. Evidence for the rewarding effects of ethanol using the conditioned place preference method;Bozarth;Pharmacol Biochem Behav,1990

5. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice;Broadbent;Alcohol,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Addiction and Drug Dependency;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022

2. Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress;Antioxidants;2021-02-26

3. Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors;Cellular Physiology and Biochemistry;2018

4. Psychosis associated with high dose of Zoletil;Psychiatry and Clinical Neurosciences;2016-07-08

5. The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies;Drug Testing and Analysis;2016-06-24